Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic

BACKGROUND: Buprenorphine and naloxone are first-line medications for people who use opioids (PWUO). Buprenorphine can reduce opioid use and cravings, help withdrawal symptoms, and reduce risk of opioid overdose. Naloxone is a life-saving medication that can be administered to reverse an opioid over...

Descripción completa

Detalles Bibliográficos
Autores principales: Dadiomov, David, Bolshakova, Maria, Mikhaeilyan, Melania, Trotzky-Sirr, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241266/
https://www.ncbi.nlm.nih.gov/pubmed/35768817
http://dx.doi.org/10.1186/s12954-022-00651-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241266/
https://www.ncbi.nlm.nih.gov/pubmed/35768817
http://dx.doi.org/10.1186/s12954-022-00651-3

Ejemplares similares